Cognitive and behavioral abnormalities in individuals with Alzheimer’s disease, mild cognitive impairment, and subjective memory complaints

Author:

Warren Samuel L.ORCID,Reid Edwina,Whitfield Paige,Helal Ahmed M.,Abo Hamza Eid G.,Tindle Richard,Moustafa Ahmed A.,Hamid Mohamed S.

Abstract

AbstractIn this study, we investigated the ability of commonly used neuropsychological tests to detect cognitive and functional decline across the Alzheimer’s disease (AD) continuum. Moreover, as preclinical AD is a key area of investigation, we focused on the ability of neuropsychological tests to distinguish the early stages of the disease, such as individuals with Subjective Memory Complaints (SMC). This study included 595 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset who were cognitively normal (CN), SMC, mild cognitive impairment (MCI; early or late stage), or AD. Our cognitive measures included the Rey Auditory Verbal Learning Test (RAVLT), the Everyday Cognition Questionnaire (ECog), the Functional Abilities Questionnaire (FAQ), the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog), the Montreal Cognitive Assessment scale (MoCA), and the Trail Making test (TMT-B). Overall, our results indicated that the ADAS-13, RAVLT (learning), FAQ, ECog, and MoCA were all predictive of the AD progression continuum. However, TMT-B and the RAVLT (immediate and forgetting) were not significant predictors of the AD continuum. Indeed, contrary to our expectations ECog self-report (partner and patient) were the two strongest predictors in the model to detect the progression from CN to AD. Accordingly, we suggest using the ECog (both versions), RAVLT (learning), ADAS-13, and the MoCA to screen all stages of the AD continuum. In conclusion, we infer that these tests could help clinicians effectively detect the early stages of the disease (e.g., SMC) and distinguish the different stages of AD.

Publisher

Springer Science and Business Media LLC

Subject

General Psychology

Reference56 articles.

1. Aisen, P. S., Cummings, J., Jack, C. R., Jr, Morris, J. C., Sperling, R., Frolich, L., Jones, R. W., Dowsett, S. A., Matthews, B. R., Raskin, J., Scheltens, P., & Dubois, B. (2017). On the path to 2025: Understanding the Alzheimer's disease continuum. Alzheimer's Research & Therapy, 9(1), 60. https://doi.org/10.1186/s13195-017-0283-5.

2. Alashwal, H., Diallo, T. M. O., Tindle, R., & Moustafa, A. A. (2020). Latent class and transition analysis of Alzheimer’s disease data. Frontiers in Computer Science, 2, 551481.

3. Alzheimer’s Disease International. (2015). World Alzheimer report 2015. https://www.alzint.org/resource/worldalzheimer-report-2015/

4. Alzheimer’s Disease Neuroimaging Initiative (2008). ADNI2 procedures manuals. https://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf

5. Alzheimer’s Disease Neuroimaging Initiative (2017). ADNI3 procedures manuals. http://adni.loni.usc.edu/adni-3/procedures-manuals/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3